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Na/Ca2 exchangers (NCX) constitute a major Ca2 export
system that facilitates the re-establishment of cytosolic Ca2
levels in many tissues. Ca2 interactions at its Ca2 binding
domains (CBD1 and CBD2) are essential for the allosteric regu-
lation of Na/Ca2 exchange activity. The structure of the
Ca2-bound form of CBD1, the primary Ca2 sensor from
canine NCX1, but not the Ca2-free form, has been reported,
although the molecular mechanism of Ca2 regulation remains
unclear. Here, we report crystal structures for three distinct
Ca2 binding states of CBD1 from CALX, a Na/Ca2
exchanger found in Drosophila sensory neurons. The fully
Ca2-boundCALX-CBD1 structure shows that fourCa2 atoms
bind at identical Ca2 binding sites as those found in NCX1 and
that the partial Ca2 occupancy and apoform structures exhibit
progressive conformational transitions, indicating incremental
regulation of CALX exchange by successive Ca2 binding at
CBD1. The structures also predict that the primary Ca2 pair
plays the main role in triggering functional conformational
changes. Confirming this prediction, mutagenesis of Glu455,
which coordinates the primary Ca2 pair, produces dramatic
reductions of the regulatory Ca2 affinity for exchange current,
whereas mutagenesis of Glu520, which coordinates the second-
ary Ca2 pair, hasmuch smaller effects. Furthermore, our struc-
tures indicate that Ca2 binding only enhances the stability of
the Ca2 binding site of CBD1 near the hinge region while the
overall structure of CBD1 remains largely unaffected, implying
that the Ca2 regulatory function of CBD1, and possibly that for
the entireNCX family, ismediated throughdomain interactions
between CBD1 and the adjacent CBD2 at this hinge.
TheNa/Ca2 exchanger (NCX)3 plays an important role in
eukaryotic Ca2 homeostasis. This transporter functions as a
Ca2 efflux mechanism across cell membranes and broadly
participates in Ca2-mediated cellular signaling. NCXs have
been identified in numerous tissues and cell types from several
different species. In cardiacmuscle, NCX1.1 plays a critical role
in transsarcolemmal Ca2 efflux, an essential requirement for
cardiac relaxation (1). In neuronal tissues, a variety of exchang-
ers are intricately involved in the control of excitation-secretion
signaling (2). Notably, all characterized mammalian Na/Ca2
exchangers exhibit a common Ca2-dependent regulatory
mechanism, whereby their activity requires the presence of low
concentrations of Ca2 on their intracellular surface, and their
activity is augmented in parallel with elevated intracellular
Ca2 levels (3). This important regulatory propertymay permit
the timely coupling of exchange function to alterations in intra-
cellular Ca2 concentrations to meet the continuous needs for
overall Ca2 balance.
The general similarities of exchange function and regulatory
properties within the large NCX protein family are ascribed to
their conserved structural arrangements: nine predicted trans-
membrane (TM) segments form the ion translocation pathway
and a large loop of500 amino acid residues splits TM helix-5
and -6 on the intracellular side of the molecule (4). Ca2-de-
pendent regulation is attributed exclusively to Ca2 interac-
tions on the intracellular loop (5). A pair of Ca2 binding
domains (CBD1 and -2), called CALX-motifs, has been iden-
tified (6). Sequence analysis revealed that CBD1 has conserved
Ca2binding sites throughout theNCX family, whereas greater
sequence diversity and/or Ca2 binding capabilities occurs in
CBD2 (7, 27). Given that CBD1 exhibits a higher Ca2 affinity
than CBD2 (8), it has been suggested that CBD1 acts as the
primary sensor in the pair of CBDs. Mutations of carboxylate
residues at CBD1 result in a pronounced reduction of the affin-
ity for functional Ca2 regulation (9). The Ca2-bound struc-
tures of CBD1 of NCX1 have recently been determined by
NMR, and more recently by x-ray crystallography (8, 11). The
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crystal structures revealed that fourCa2 ions bind at the end of
a -sandwich structure of CBD1. More recently, a detailed
study by backboneNMR suggested that Ca2 binding induces a
selective conformational change of CBD1 limited to the resi-
dues in the binding site, whereas the core of the -sandwich
structure remains unaffected (12). These observations raise a
fundamental question of how the primary sensor role of CBD1
is conducted to the TM segments to control exchange activity.
There is currently no structure available for the apoform of
CBD1. Consequently, there is no related mechanistic informa-
tion or insight into how Ca2 binding induces the conforma-
tional change of CBD1 required for transduction of this signal.
In the reportedCa2-boundNCX1-CBD1 crystal structure, the
Ca2 binding site was saturated with four Ca2 atoms (11).
Whether these four Ca2 access the binding site of CBD1
simultaneously or in a sequential way is unknown. Information
of this type is critical toward understanding whether exchange
function is simply switched on or off by Ca2 or whether vari-
ous degrees of exchange function are graded by different levels
of Ca2 occupancy.
CALX, a Na/Ca2 exchange protein, was first identified in
Drosophila photoreceptor cells (6, 13, 24). CALX is responsible
for extruding intracellular Ca2 from these cells and plays an
essential role in light-mediated signaling inDrosophila sensory
neurons (14). CALX shares 49% amino acid identity with the
prototypical canine Na/Ca2 exchanger, NCX1.1. Function-
ally, it sharesmany properties found inmammalian exchangers
(13). However, CALX exhibits a completely opposite response
to regulatory Ca2 compared with all other characterized
mammalian NCX homologs: the highest activity of CALX
occurs in the complete absence of regulatoryCa2 and its activ-
ity is progressively inhibited, rather than stimulated, by eleva-
tions in intracellular regulatory [Ca2]. This negative Ca2 reg-
ulation of CALX leads to a considerable loss of signal
amplification in the light response of theDrosophila visual sys-
tem that triggers the photoreceptor cell cascade (14). CALX
also possesses a pair of CBD domains on its intracellular loop.
The mechanism underlying the negative Ca2 regulatory phe-
notype observed for CALX is still elusive and enigmatic based
on the existing structural information for NCX1. Our recent
crystal structure of CALX-CBD2 showed that this site is not a
functional Ca2 binding site, suggesting that CBD1must be the
critical site involved in Ca2 regulation of CALX (7). Further-
more, structural predictions, together with previous mutagen-
esis studies (7, 15) have strongly suggested that CALX-CBD1
possesses a similar Ca2 binding site as does NCX1. To gain
further insight into the Ca2-binding mechanisms of Na/
Ca2 exchange proteins in atomic detail and to investigate the
negative Ca2 regulatory property of CALX, we have deter-
mined crystal structures of CBD1 from CALX1.1 in the pres-
ence and absence of Ca2 and studied the properties of this
regulatory mechanism by mutagenesis and electrophysiology.
EXPERIMENTAL PROCEDURES
Expression and Purification of CALX-CBD1 Domains—The
gene fragments encoding the CBD1 (amino acids 442–554)
from a full length cDNA of Drosophila CALX1.1 were cloned
into the vector pET28a (Novagen) with restriction sites of
NdeI/XhoI. In the generated plasmid, CBD1 has an N-terminal
His-tag spaced by a thrombin cleavage site. Protein expression
was performed in Escherichia coli BL21(DE3) cells in the auto-
induction medium (16) overnight at 25 °C. The cell pellet was
suspended in a lysis buffer containing 50 mM sodium phos-
phate, 500mMNaCl, 20mM imidazole, pH 8.0, and ruptured by
a high pressure homogenizer (Avestin). The lysate supernatant
was applied to a nickel-nitrilotriacetic acid resin column (GE
Healthcare), and the CALX-CBD1 protein was eluted with 300
mM imidazole. The purified protein was dialyzed overnight
against a Tris-buffered saline buffer, pH 7.4, and was incubated
with thrombin protease (GE Healthcare) overnight at 4 °C to
truncate the His-tag. The proteolytic reaction mixtures were
reapplied to nickel-nitrilotriacetic acid resin and the pass-
through containing untagged CALX-CBD1 proteins was con-
centrated by Centricon (Millipore) and further purified by size-
exclusion chromatography using a Superdex 75 10/300 GL
column (GEHealthcare). The protein concentrationwas deter-
mined with a Coomassie protein determination kit (Pierce).
Crystallization of CALX-CBD1—All crystallization experi-
ments were performed using the sitting-drop vapor diffusion
method at 18 °C. CALX-CBD1, premixed with 1 mM CaCl2 at a
protein concentration of 10 mg/ml, was crystallized using the
following conditions: 50 mM MES, pH 6.0, 20% polyethylene
glycol 3350. To obtain the apoform crystals, CALX-CBD1 pro-
tein was incubated with 10mM EDTA for 1 h and then dialyzed
against Tris-buffered saline buffer, pH 7.4, prior to the crystal-
lization experiment. The apoform crystals were obtained under
different conditions using 100 mM Bis-Tris, pH 6.5, 200 mM
NH4Ac, 10 mM MgCl2, 15% polyethylene glycol 10,000.
DataCollection—All crystals were flash-cooled to 100Kwith
25% glycerol as the cryoprotectant. Diffraction data for the
Ca2 form crystal of CBD1 were collected at beamline X06SA
of the Swiss Light Source (Villigen). A long wavelength (1.90 Å)
was used for data collection with the intention of exploiting
weak anomalous signals from Ca2 atoms. The data collection
for the apoform of CBD1was carried out at the Advanced Light
Sources beam line 4.2.2 (Berkeley, CA).
Data Processing and Structural Determination—Data proc-
essing, merging, and reduction were carried out with programs
XDS and XSCALE (17). The CALX-CBD1 structures were
solved using the molecular replacement method by the pro-
gram PHASER (18) and using the CBD1 structure from NCX1
(Protein Data Bank code 2DPK) as a search model. Both struc-
tures were refined using the program Refmac (19). The model
building was performed using COOT (20). Crystallographic
data and the model refinement statistics are given in Table 1.
The anomalous Fourier map in Fig. 1Awas calculated using the
program FFT (21) with phases from the final refined coordi-
nates and observed anomalous difference in diffraction data.
All figures were prepared using the program PyMOL (22).
Circular Dichroism (CD) Spectroscopy—Prior to CD spectro-
scopic analysis, CALX-CBD1 protein used for crystallization
was passed through a desalting column (GE Healthcare) equil-
ibrated with a solution containing 200 mM NaF, pH 7.4, to
remove any Cl. The protein concentration was adjusted to 1
mg/ml before measurement. CD spectra of the CBD1 protein
were collected at room temperature over a wavelength range
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from 190 to 260 nm with a Jasco J-720 spectrometer using a
0.02-cm cylindrical cell.
Mutational Analysis Using Giant Excised Patch Clamping—
Mutations of CALX1.1 were introduced by a modified site-di-
rected mutagenesis procedure (23). To exclude the possibility
of random PCR errors on large cNDA of CALX (3 kb), a
minimal DNA fragment containing the sequencing-confirmed
mutations was recloned back to the parent vector with appro-
priate restriction sites.
The effect of each mutation on Ca2 regulation of CALX1.1
wasmeasured by outwardNa-Ca2 exchange current record-
ings using the giant, excised patch clamp technique, as
described previously (24). Briefly, Xenopus laevis oocytes were
injected with 23–35 ng of cRNA of wild-type or mutant
CALX1.1 and maintained at 18 °C. Electrophysiological mea-
surements were typically obtained from day 3 to 7 postinjec-
tion. Borosilicate glass pipettes were pulled and polished to a
final, inner diameter of 20–30 m, and coated with a
Parafilm:mineral oil mixture to enhance patch stability and
reduce electrical noise. Oocytes were briefly (5–10 min)
transferred to a solution containing: 100 mM KOH, 100 mM
K-aspartate, 100 mM MES, 20 mM HEPES, 10 mM NH3SO3, 5.0
mM EGTA, 5.0 mM Mg(OH)2; pH 7.0, at room temperature
(withMES) to allow sufficient shrinkage of the cells in order for
their vitellin layers to be removed by dissection. Giga ohm seals
were formed by gentle suction, and membrane patches were
excised by progressive movements of the pipette tip. Rapid
solution changes were introduced using computer-controlled,
multi-channel perfusion devices. Axon Instruments hardware
and softwarewere used for data acquisition.Aholding potential
of 0 mV was employed for all current measurements.
Pipette solutions contained 100 mM N-methyl-D-glucamine,
100 mMMES, 30 mMHEPES, 30 mM TEA-OH, 16 mM sulfamic
acid, 8.0 mM CaCO3, 6.0 mM KOH, 0.25 mM ouabain, 0.1 mM
flufenamic acid, 0.1 mM niflumic acid; pH 7.0, at room temper-
ature (with MES). Currents were elicited by switching from
Li- to Na-based perfusion solutions containing: 100 mM
NaOH or LiOH, 100 mM L-aspartic acid, 20 mM CsOH,
20mMHEPES, 20mMTEA-OH, 10mM EGTA, 3.00–21.84mM
NH3SO3, 0–9.91 mMCaCO3, 1.00–1.50 mMMg(OH)2; pH 7.0,
at 30 °C (with MES or LiOH). Stock solutions of CaCO3 and
Mg(OH)2 were prepared in a ratio of 1:2 with sulfamic acid.
Total Mg2 and Ca2 were adjusted to yield free concentra-
tions of 1.00 mM and 0–30 M, respectively, usingMAXC soft-
ware (25).
All experiments were conducted at 30 °C. Origin software
was used for curve-fitting and statistical analyses. Pooled data
are mean S.E. Student’s t test or one-way analysis of variance
and Tukey’s post hoc test, were used for statistical determina-
tions. p 0.05 was considered significant.
RESULTS
Overview of CALX1.1-CBD1 Structure—The Ca2-bound
structure of CALX-CBD1 was determined at 2.25 Å resolution.
The structure showsCALX-CBD1has an immunoglobulin-like
conformation formed by two anti-parallel -sheets consisting
of -strands, A, B, G and C, D, E, F, respectively (Fig. 1A).
CALX-CBD1 shares 60% sequence identity with that of canine
NCX1-CBD1. Consequently, these two structures can be
superimposed with a root mean square deviation of 0.84 Å for
113 aligned C atoms. Themost significant difference between
these two CBD1 structures occurs within their F-G loops.
CALX-CBD1 has a rather short F–G loop with only 9 residues,
whereas its counterpart fromNCX1 consists of 28 residues and
displays high flexibility, as indicated in the NMR structure (8).
Ca2 Binding Site of CALX-CBD1—The Ca2- bound
CALX-CBD1 crystal diffraction data set was collected at 1.9 Å
wavelength, allowing the assignment of the bound Ca2 by
examination of the anomalous signal (Fig. 1A). Four Ca2 are
clustered in the distal loops of the -sandwich with4 Å equal
distance spacing between them. Nine carboxylate residues are
involved in the coordination of Ca2 (Fig. 1B). The side chains
of these acidic residues are arranged in a zipper-like orienta-
tion, forming an extensive carboxylate cluster at the top of this
-sandwich. The E–F loop is themajor component in the Ca2
binding site with five of its residues involved in Ca2 coordina-
tion. That is, the E–F loop crosses over the Ca2 zipper line
clamping Ca-1, -2, and -3 ions through coordination with car-
boxylate groups of Asp515, Asp516, andGlu520 together with the
carbonyl oxygen atoms of Asp517 and Val518. Compared with
Ca-1 or -2, which is penta- or hexacoordinated, Ca-4 is only
tricoordinated with Asp490, Glu523, and Glu520. Consequently,
Ca-4 displays the highest thermal B factor, suggesting it may be
the most mobile species during these ligand interactions.
FIGURE 1. Crystal structures of CALX-CBD1. A, structural alignment of the
CBD1 fromCALXandNCX1. CALX-CBD1 shownas rainbow ribbonswas super-
imposed on the NCX1-CBD1 crystal structure shown in gray. The anomalous
difference map is displayed in slate and contoured at 6.0 to indicate the
Ca2 positions. The short F–G loop of CALX is highlighted, whereas that from
NCX1 is invisible. B, structural alignment of the Ca2 binding sites of CALX-
CBD1 and NCX1-CBD1. The Ca2-bound CALX-CBD1 structure in cyan is
superimposed onto the NCX1-CBD1 structure (colored in wheat). Four Ca2
and water molecules are represented as green and red spheres, respectively.
The residues coordinating Ca2 are shown as stick balls; Ca2 interactions
with residues are shown as yellow dashed lines. The label for the E385 residue
in NCX1 is shown in underlined italics.
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The Ca2 binding sites of CALX-CBD1 are almost identical
to those of NCX1 except for Glu455, which locates centrally on
the basement of the binding site. Compared with the NCX1
structure, this residue rotates its carboxyl group by 90°, result-
ing in simultaneous coordination with three Ca2 (Ca-1, Ca-2,
and Ca-3) instead of one (Ca-2) shown in the NCX1-CBD1
structure (11). In addition, it appears that the disulfide bridge
locking the A–B loop near Glu385 in
theNCX1-CBD1 structure is absent
in CALX-CBD1, as a valine replaces
cysteine at position 453.
Conformational Change in the
Apoform Structure—To gain addi-
tional structural information regard-
ing Ca2 binding to CBD1, the
CBD1 protein was treated with 10
mM EDTA and dialyzed prior to
crystallization; the apoform struc-
ture was determined at 1.6 Å resolu-
tion. The EDTA-treated sample
gives the same crystal packing as
that of the Ca2-bound form; four
monomers assemble in anti-parallel
in an asymmetric unit. The overall
structure of the apoform CBD1
shows no overall conformational
changes compared with the Ca2-
bound form except within the Ca2
binding sites. In the Ca2-bound
structure, Ca2 binding sites of four
monomers in an asymmetric unit
were identically and fully occupied.
In contrast, the same binding sites
exhibit three distinct Ca2 bind-
ing states in the apoform struc-
ture. Monomer B shows a full
occupancy state as shown in the
Ca2-form structure, where four
Ca2were found in the Ca2 bind-
ing site and all residues involved in
Ca2 coordination are clearly vis-
ible (Fig. 2A).
However, monomer A displays a
partial Ca2 binding state. Only
Ca-1 and -2 (the primary Ca2 pair)
were found at similar positions as in
monomer B (Fig. 2B). The absence
of Ca-3 and Ca-4 (named as the sec-
ondary Ca2 pair) does not result in
any significant structural change
compared with monomer A with
root mean square deviation values
of 0.28 Å for backbone atoms and
0.68 Å for all atoms. The conforma-
tional change occurs exclusively at
Glu520, whose side chain is invisible
in the electron density map. The
backbone of the entire E–F loop is
still clearly resolved and appears to be stabilized by the primary
Ca2pair.However, the thermal B factors of the residues on the
E–F loop are considerably increased compared with those in
monomer B (Fig. 3). A water molecule at position 265 was
found at Ca-3 position, which forms two hydrogen bonds with
Glu455 and Asp490. No density can be observed in the Ca-4
position. The conformations of Asp490 and Glu523 remain
FIGURE 2. Stereo views of conformational changes in the Ca2 binding sites of CALX-CBD1. 2Fo  Fc
electron densitymaps contoured at 1.5 level are shown in blue. Ca2 andwatermolecules are represented as
green and red spheres, respectively. The residues coordinating Ca2 are shown as stick balls. Hydrogen bond
interactions are shownas yellowdashed lines.A,B, andC represent threedifferent conformations fromthe same
asymmetric unit of the apoform CALX-CBD1 structure. A, monomer B (four Ca2-bound); B, monomer A (two
Ca2-bound); and C, monomer C (no Ca2-bound).
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unchanged; they are stabilized by a hydrogen bond network
with a water molecule at position 324.
Strikingly, both monomers C and D represent the true apo-
form, and no Ca2 can be found in corresponding regions (Fig.
2C). Nearly all residues involved in Ca2 binding become invis-
ible, particularly the entire E–F loop (Asp516–Glu522), which
strongly suggests that the primary Ca2 pair plays a critical role
in stabilizing the entire Ca2 binding region. The disorder of
the Ca2 binding region has no impact on the overall -sheet
structure of CBD1 and the neighboring C–D loop containing
Asp490 is still clearly resolved. Both Ca2-free forms superim-
posewell with similar rootmean square deviation values of 0.44
Å for backbone atoms and 0.97 Å for all atoms. Notably, no
Ca2 binding region from these four monomers is involved in
crystal packing, and all four monomers display comparable
thermal B factors (Table 1 and Fig. 3).
Our structural observations indicate that no gross conforma-
tional changes occur during Ca2 binding. To exclude any pos-
sible effects of crystallization constraints, the Ca2 extraction
experiment was performed in solution with monitoring by CD
spectroscopy. The result shows CBD1 protein exhibits a full
-strand conformation, as expected (Fig. 4A). No detectable
change of protein secondary structurewas observed by addition
of either 2 mM Ca2 (Fig. 4B) or 10 mM EDTA (Fig. 4C). Nota-
bly, 10mMEDTAcauses Ca2 unbinding of CBD1 ofNCX1 (8).
Mutational Analysis of Ca2 Binding Site of CBD1—Two
residues, Glu455 and Glu520, are involved in the coordination of
three Ca2 at the CBD1 site, although they differ in the specific
Ca2 ions which are involved (Glu455 with Ca-1, -2, and -3;
Glu520 with Ca-2, -3, and -4). Our structural data suggest that
Glu455, which coordinates the primary Ca2 pair, plays a more
important role in stabilizing the entire Ca2 binding region
than Glu520. To examine whether these two glutamate residues
have unequal functions in the Ca2-dependent regulatory
mechanism, they weremutated into Asp and/or Ala. RNA from
either the wild-type CALX1.1 or various mutant exchangers
was injected into Xenopus laevis oocytes, and the outward cur-
rents were recorded to evaluate functional Ca2 regulation.
The overlapping traces in Fig. 5A show representative outward
Na-Ca2 exchange currents for wild-type CALX1.1 at four
different Ca2 concentrations. In the absence of regulatory
Ca2, CALX is fully activated by the application of 100 mM
Na. However, both peak and steady-state currents become
substantially suppressed by increasing the concentration of
regulatory Ca2. (Results obtained at 1, 3, and 10 M are
shown.) The corresponding IC50s for peak and steady-state cur-
rents are 0.4 0.1 M and 0.13 0.002 M, respectively.
Even though Glu520 appears to have the equivalent Ca2
coordinating capacity as Glu455 (i.e. three Ca2), it exhibits far
less importance in mediating the Ca2 regulatory response.
Mutations of these two residues illustrate their different func-
tional roles. The Ca2 dependence of peak and steady-state
currents of thesemutants are presented in Fig. 5, E and F. In the
FIGURE 3. Thermal B values versus residues in eachmonomer of an asym-
metric unit of CALX-CBD1 structure. A, monomer B; B, monomer A; C, mon-
omer C; and D, monomer D.
TABLE 1
Data processing andmodel refinement statistics for CALX-CBD1
structures
CALX-CBD1
Ca2-bound form
CALX-CBD1
apoform
Data collection
Space group P212121 P212121
Unit cell (Å) 59.4, 73.7, 129.7 59.1, 76.5, 129.0
Wavelength (Å) 1.90 1.00
Resolution range (Å)a 20–2.25 (2.3–2.25) 47.6–1.6 (1.70–1.60)
Observations (total/unique) 196,637/26,203 553,318/146,906
I/ (I)a 14.1 (3.1) 15.6 (2.0)
Completeness (%)a 94.4 (71.8) 98.7 (95.8)
Rsym (%)a 7.2 (54.4) 10.7 (57.7)
Structure refinement
Rwork/Rfree 20.8/26.5 19.2/22.1
Number of atomsb 3,596/16/120 3,482/6/461
r.m.s.d.c bond length (Å) 0.017 0.012
r.m.s.d. bond angle 1.76° 1.63°
Ramachandran analysis (%)
Most favored 91.2 91.5
Additional favored 8.8 8.2
Generously allowed 0 0.3
B factors (average)
Monomer A/B/C/D 47.7/45.3/46.1/62.3 20.4/18.7/21.2/23.2
Ca2 64.5 25.7
Water 39.1 32.1
a Values within parentheses refer to the high resolution shell.
bNon-hydrogen protein atoms/metal atoms/water molecules.
c r.m.s.d., root mean square deviation.
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E520A mutation, there is only a slight reduction in the inhibi-
tory potency of regulatory Ca2 for peak currents, (IC50s 
1.2  0.01 M) and even less for steady-state currents (0.22 
0.06 M) (Fig. 5B).
In sharp contrast, the Ca2 response is much more sensitive
to changes at residue Glu455. The E455A mutation results in a
dramatic alteration of the Ca2 regulatory response. Both peak
and steady-state currents are not appreciably inhibited until the
level of regulatory Ca2 reaches 3 M (Fig. 5D). The apparent
Ca2 affinity of E455A for regulation of peak currents is
reduced by20-fold to IC50 8.1 0.5 M. Steady-state cur-
rents show an even greater reduction in the inhibitory potency
of regulatory Ca2, which drops by 35-fold to 3.5 0.2M.We
also mutated Glu455 to an Asp. Similar to E455A, as shown in
Fig. 5C, this conservativemutant shows a large shift in the affin-
ity for functional Ca2 regulation, which now appears at the
level of 1MCa2. The inhibitory potency of regulatoryCa2 is
reduced by nearly 17-fold for both peak (6.7  1.3 M) and
steady-state currents (1.7 0.1M). These results clearly dem-
onstrate that residue Glu455 is essential for Ca2 binding and
ultimately the transduction of the regulatory Ca2 binding sig-
nal. The integrity of Glu455 is critical in maintaining normal
exchanger regulation of CALX.
DISCUSSION
Ca2 interactions occurring at CBD1 are essential for prop-
erly controlling sodium-calcium exchange activity and for the
maintenance and reestablishment of resting Ca2 levels in liv-
ing cells. In this study, the Ca2-bound structure of CALX-
CBD1 precisely confirms the occupancy of four Ca2 within
this site by their anomalous signals. Our data shows that CALX
has a similar overall structure andCa2 binding site of CBD1 as
does themammalianNCX1, irrespective of their opposite Ca2
regulatory phenotypes. Therefore, Ca2 binding within the
CBD1 structures likely represents a general mechanism within
the larger NCX family.
Despite the nearly identical sequence composition of the
Ca2 binding sites within CBD1 from either CALX or NCX1,
both the Ca2-bound and apoform CALX-CBD1 structures
consistently demonstrate that Glu455 in the core of the Ca2
binding site plays a significantly different role in Ca2 coordi-
nation compared with Glu385 in the NCX1 structure. Possibly,
this difference betweenCALXandNCX1 could be attributed to
the lower resolution (2.5 Å) of the
NCX1 structure (11). The oxygen
atoms of the carboxylate group of
Glu385were notwell defined, as seen
in the electron density of the NCX1
structure. To date, no mutations of
Glu385 inNCX1have been reported.
Given the remarkable impact of
Glu455 mutations, we would predict
that thisGlu residue plays an impor-
tant role in the Ca2 regulatory
mechanism of mammalian NCX1
and other exchanger proteins.
All characterized exchangers show
concentration-dependentCa2 regu-
latory effects. For example, CALX, as seen in Fig. 5A, responds in
a graded manner to the progressive administration of regula-
tory Ca2. In contrast to NCX1-CBD2 (8, 10), CALX-CBD2
does not have Ca2 binding capabilities (7). CBD1 is the only
Ca2 binding region within the entire Ca2 regulatory domain
that could be responsible for this progressive negative Ca2
regulatory phenotype. Therefore, the graded Ca2 regulation
exhibited in Fig. 5Amust represent regulatory Ca2 binding at
CBD1. However, with only Ca2-bound structures, previously
reported for CBD1 (8, 11), it is impossible to distinguish
whether Ca2 regulation at the level of a single exchanger pro-
tein constitutes an all-or-none versus a graded Ca2 binding
phenomenon.
In this study, we determined the apoform structure of CBD1
as well as that of an intermediate with two, rather than four,
Ca2 bound. The apoform structure clearly indicates that the
primary Ca2 pair is critical for the stabilization of the entire
Ca2 binding site of CBD1 whereas the effect of the secondary
Ca2pair is quitemodest. This is consistentwith our functional
analysis, wheremutations that altered Glu455 (coordinating the
primary Ca2 pair) strongly disrupted Ca2 regulation,
whereasmutations of Glu520 (coordinating the secondary Ca2
pair) only resulted in subtle reductions of Ca2 affinity. These
twoCa2 pairs also interact with other carboxylate groups (Fig.
1B). Given themodest effect of the other carboxylate residues in
the Ca2 binding site of CBD1 suggested by a previous
mutagenesis study (15), the affinity of E520Amutant (0.13 M)
or E455A (3.5 M) should approximate the affinities for the
primary Ca2 pair or the secondary Ca2 pair, respectively.
Calcium concentrations of 0.13–3.5 M would correspond to
the reactive concentration range of regulatory Ca2 for CBD1.
In the dynamic Ca2 environment of living cells, the primary
Ca2 pair with its higher affinity is expected to access CBD1
initially to establish the conformational transitions. These
observations clearly elucidate that the four Ca2 access the
binding site of CBD1 in a sequential manner, rather than by
simultaneous occupation.
The mechanism through which occupancy of the CBDs by
Ca2 is ultimately transduced to the transport machinery
within the TM segments remains unknown. A plausible theory
would be that substantial conformational changes occur upon
Ca2 binding, which are subsequently transmitted to the trans-
portmachinery. In fact, a fluorescent resonance energy transfer
FIGURE 4.CDspectra of CALX-CBD1uponCa2binding.A, CBD1protein after the protein purification; B, the
CBD1 protein with 2 mM Ca2; and C, the CBD1 protein with 10 mM EDTA.
Conformational Transitions of CBD1 by Ca2 Binding
JANUARY 22, 2010•VOLUME 285•NUMBER 4 JOURNAL OF BIOLOGICAL CHEMISTRY 2559
study with NCX1 indicated that Ca2 binding elicits a confor-
mational change of CBD1 (26). The apoform structure shows
that CBD1maintains the integrity of its -sandwich conforma-
tion regardless of Ca2 binding, whereas conformational
changes caused by Ca2 interactions are limited to the residues
in the Ca2 binding region as examined by CD spectroscopy
and x-ray crystallography, arguing that a change of quaternary
structure of CBD1 is not a requirement for the Ca2 regulatory
mechanism. Occupancy by the primary Ca2 pair only affects
the stabilization of the Ca2 binding site, especially within the
E–F loop, as has also been shown for NCX1-CBD1 by NMR
(12). Considering the fact that the E–F loop locates to theCBD1
domain surface, we propose that the Ca2 binding signal is
transduced from the E–F loop by communication to adjacent
domain(s).
For all NCX proteins, the C terminus of CBD1must connect
with the N terminus of CBD2 in a very compact manner, pro-
viding the strong possibility that the Ca2 binding site, partic-
ularly the E–F loop of CBD1, interacts with the N-terminal
region of CBD2. Our mutational analysis shows that carboxy-
late residues in the Ca2 binding sites of CBD1 serve unequal
roles in the Ca2 regulatory mechanism (Fig. 5). Notably, the
essential residue Glu455 locates very close to the link or hinge
region, further supporting the possibility that the signal of Ca2
binding is transduced through this link via domain interactions
between CBD1 and CBD2. This possibility is also strongly sup-
ported by our previous mutational analysis, where a proline
mutation of Gly555 completely eliminated the Ca2 regulatory
properties of CALX (15). This proline mutation occurs at the
joint between CBD1 and CBD2 and presumably disrupts CBD
domain interactions.
Overall, our results support a mechanistic hypothesis that
Ca2 binding/unbinding at CBD1 is transduced through the
interdomain interactions between the Ca2 binding sites of
CBD1 and CBD2 and that the E–F loop of CBD1 acts as a hinge
for this domain interaction. As a consequence, Ca2 binding at
CBD1 stabilizes the E–F loop and in turn changes the orienta-
tion between these two rigid domains to influence the motion,
ion access, or functionality of the transmembrane segments.
Given that similar effects are also reported for the analogous
mutation, G503P, in NCX1 (9), this general Ca2 regulatory
mechanism may also be applicable to the larger Na/Ca2
exchanger protein family.
Based on our structural and functional analysis, we hypoth-
esize that the Ca2 regulatory mechanism occurring via CBD1
for CALX is performed in two sequential steps, as follows
(Scheme 1): 1) CALX remains fully active when CBD1 exists in
its apoform; 2) the primary pair of Ca2 ions accesses the bind-
ing site to stabilize the E–F loop and alters the domain orienta-
tion angle between CBD1 and CBD2, generating a conforma-
tional change of the TM segments to initiate transporter
inactivation; 3) as the Ca2 concentration increases, the sec-
ondaryCa2 pair binds toCBD1, stabilization of the E–F loop is
further enhanced, and the TM transport machinery becomes
more completely inactivated by stabilization of this inactive
FIGURE5.RepresentativeoutwardNa/Ca2exchange currents showing
the regulatory Ca2 dependence of the wild-type and various CALX1.1
mutant exchangers. 8mMCa2was present in the pipette, and the currents
were activated by the addition of 100 mM Na to the cytoplasmic surface of
the patch with regulatory Ca2 absent or present at various concentrations.
For wild-type (A), E455D (C) and E455A (D), exchange currents were recorded
at four different Ca2 concentrations (0, 1, 3, and 10 M) as indicated. For
E520A (C), only three different Ca2 concentrations (0, 1, and 3 M) were
tested. Ca2i dependence of pure outward currents for peak (E) and steady
state (F) mediated by wild-type CALX1.1 and various mutants. Currents were
normalized to those obtained at 0 Ca2i within the same patch. Data points
were averaged from four to seven individual patches. IC50 for peaks: 0.4 0.1,
1.2 0.01, 6.7 1.3, and 8.1 0.5 M Ca2 for CALX1.1, E520A, E455D, and
E455A, respectively. IC50 for steady-state currents: 0.13 0.002, 0.22 0.06,
1.7  0.1, and 3.5  0.2 M Ca2 for CALX1.1, E520A, E455D, and E455A,
respectively.
SCHEME1.HypotheticalmechanismofCa2 regulation for theCALXNa/
Ca2 exchanger.
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state. Notably, such notions are becoming increasingly testable
based on existing structure-function studies.
The graded nature of Ca2 regulatory effects are even more
pronounced for NCX1 than for CALX. In NCX1, Na/Ca2
exchange currents are triggered by submicromolar Ca2 levels
and are amplified almost continuously by higher Ca2 levels
exceeding 10 M, presumably in response to the much larger
changes in intracellular Ca2 levels that occur in cardiac myo-
cytes. Our structures provides solid evidence that stepwise reg-
ulation of exchange is accomplished through different Ca2
binding states in the CBD1 domain through its communication
between the two CBDs. Very recently, a comparably functional
study with NCX1 CBD1 mutants supports further application
of our hypothetic model (28). Additional understanding of this
interplay will need to be addressed by future crystallographic
studies of the entire intracellular loop in conjunction with
mutagenesis studies.
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